# TTM Technologies Inc: financial statements, quarterly

TTMI · Nasdaq · CIK 1116942 · [Technology](/sectors/technology.md) · fiscal year ends Dec 28

Pages: [Overview](/companies/ttmi.md) · [Financials](/companies/ttmi/financials.md) · [Filings](/companies/ttmi/filings.md) · [Insiders](/companies/ttmi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ttmi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2024-01-01) | Q1 FY2024 (2024-04-01) | Q2 FY2024 (2024-07-01) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-29) | Q4 FY2025 (2025-12-29) | Q1 FY2026 (2026-03-30) | Q2 FY2026 (2026-06-29) | Q3 FY2026 (2026-09-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [569 d](/filings/0001193125-26-051976.md) | [570](/filings/0000950170-25-063937.md) | [605](/filings/0000950170-25-102042.md) | [617](/filings/0001193125-25-260708.md) | [651 d](/filings/0001193125-26-051976.md) | [649](/filings/0001193125-26-201403.md) | [731](/filings/0001193125-26-335107.md) | [753](/filings/0001193125-26-435875.md) | [774 d](/filings/0001193125-26-051976.md) | [846](/filings/0001193125-26-201403.md) | [1,004](/filings/0001193125-26-335107.md) | [1,204](/filings/0001193125-26-435875.md) |
| Cost of revenue | $m | [454 d](/filings/0001193125-26-051976.md) | [466](/filings/0000950170-25-063937.md) | [488](/filings/0000950170-25-102042.md) | [487](/filings/0001193125-25-260708.md) | [524 d](/filings/0001193125-26-051976.md) | [518](/filings/0001193125-26-201403.md) | [583](/filings/0001193125-26-335107.md) | [596](/filings/0001193125-26-435875.md) | [608 d](/filings/0001193125-26-051976.md) | [665](/filings/0001193125-26-201403.md) | [792](/filings/0001193125-26-335107.md) | [912](/filings/0001193125-26-435875.md) |
| Gross profit | $m | [115 d](/filings/0001193125-26-051976.md) | [104](/filings/0000950170-25-063937.md) | [117](/filings/0000950170-25-102042.md) | [130](/filings/0001193125-25-260708.md) | [127 d](/filings/0001193125-26-051976.md) | [131](/filings/0001193125-26-201403.md) | [148](/filings/0001193125-26-335107.md) | [157](/filings/0001193125-26-435875.md) | [166 d](/filings/0001193125-26-051976.md) | [181](/filings/0001193125-26-201403.md) | [212](/filings/0001193125-26-335107.md) | [292](/filings/0001193125-26-435875.md) |
| Research and development | $m | [7.6 d](/filings/0001193125-26-051976.md) | [7.3](/filings/0000950170-25-063937.md) | [8.5](/filings/0000950170-25-102042.md) | [8.1](/filings/0001193125-25-260708.md) | [7.9 d](/filings/0001193125-26-051976.md) | [8.1](/filings/0001193125-26-201403.md) | [7.0](/filings/0001193125-26-335107.md) | [7.0](/filings/0001193125-26-435875.md) | [6.9 d](/filings/0001193125-26-051976.md) | [7.8](/filings/0001193125-26-201403.md) | [8.0](/filings/0001193125-26-335107.md) | [9.6](/filings/0001193125-26-435875.md) |
| Operating income | $m | [34.6 d](/filings/0001193125-26-051976.md) | [17.1](/filings/0000950170-25-063937.md) | [39.0](/filings/0000950170-25-102042.md) | [51.0](/filings/0001193125-25-260708.md) | [9.0 d](/filings/0001193125-26-051976.md) | [50.3](/filings/0001193125-26-201403.md) | [61.8](/filings/0001193125-26-335107.md) | [71.9](/filings/0001193125-26-435875.md) | [80.7 d](/filings/0001193125-26-051976.md) | [72.4](/filings/0001193125-26-201403.md) | [109](/filings/0001193125-26-335107.md) | [162](/filings/0001193125-26-435875.md) |
| Interest expense | $m | [13.4 d](/filings/0000950170-24-021098.md) | [12.3](/filings/0000950170-24-054464.md) | [12.2](/filings/0000950170-24-091772.md) | [11.8](/filings/0001193125-25-260708.md) | [11.2 d](/filings/0001193125-26-051976.md) | [11.5](/filings/0001193125-26-201403.md) | [11.1](/filings/0001193125-26-335107.md) | [10.4](/filings/0001193125-26-435875.md) | [12.4 d](/filings/0001193125-26-051976.md) | [10.6](/filings/0001193125-26-201403.md) | [10.5](/filings/0001193125-26-335107.md) | [12.8](/filings/0001193125-26-435875.md) |
| Income tax | $m | [0.5 d](/filings/0001193125-26-051976.md) | [3.6](/filings/0000950170-25-063937.md) | [4.2](/filings/0000950170-25-102042.md) | [10.7](/filings/0001193125-25-260708.md) | [9.2 d](/filings/0001193125-26-051976.md) | [8.8](/filings/0001193125-26-201403.md) | [4.0](/filings/0001193125-26-335107.md) | [8.8](/filings/0001193125-26-435875.md) | [11.3 d](/filings/0001193125-26-051976.md) | [8.5](/filings/0001193125-26-201403.md) | [(1.8)](/filings/0001193125-26-335107.md) | [56.9](/filings/0001193125-26-435875.md) |
| Net income | $m | [17.3 d](/filings/0001193125-26-051976.md) | [10.5](/filings/0001193125-25-260708.md) | [26.4](/filings/0001193125-25-260708.md) | [14.3](/filings/0001193125-25-260708.md) | [5.2 d](/filings/0001193125-26-051976.md) | [32.2](/filings/0001193125-26-435875.md) | [41.5](/filings/0001193125-26-435875.md) | [53.1](/filings/0001193125-26-435875.md) | [50.7 d](/filings/0001193125-26-051976.md) | [50.0](/filings/0001193125-26-435875.md) | [83.0](/filings/0001193125-26-435875.md) | [84.8](/filings/0001193125-26-435875.md) |
| Diluted EPS | $ per share | not reported | [0.10](/filings/0000950170-25-063937.md) | [0.25](/filings/0000950170-25-102042.md) | [0.14](/filings/0001193125-25-260708.md) | not reported | [0.31](/filings/0001193125-26-201403.md) | [0.40](/filings/0001193125-26-335107.md) | [0.50](/filings/0001193125-26-435875.md) | not reported | [0.47](/filings/0001193125-26-201403.md) | [0.77](/filings/0001193125-26-335107.md) | [0.79](/filings/0001193125-26-435875.md) |
| Basic EPS | $ per share | not reported | [0.10](/filings/0000950170-25-063937.md) | [0.26](/filings/0000950170-25-102042.md) | [0.14](/filings/0001193125-25-260708.md) | not reported | [0.32](/filings/0001193125-26-201403.md) | [0.41](/filings/0001193125-26-335107.md) | [0.51](/filings/0001193125-26-435875.md) | not reported | [0.48](/filings/0001193125-26-201403.md) | [0.80](/filings/0001193125-26-335107.md) | [0.80](/filings/0001193125-26-435875.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2024-01-01) | Q1 FY2024 (2024-04-01) | Q2 FY2024 (2024-07-01) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-29) | FY2025 (2025-12-29) | Q1 FY2026 (2026-03-30) | Q2 FY2026 (2026-06-29) | Q3 FY2026 (2026-09-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [450](/filings/0000950170-25-024839.md) | [440](/filings/0000950170-24-054464.md) | [446](/filings/0000950170-24-091772.md) | [470](/filings/0000950170-24-121449.md) | [504](/filings/0001193125-26-051976.md) | [411](/filings/0000950170-25-063937.md) | [448](/filings/0000950170-25-102042.md) | [491](/filings/0001193125-25-260708.md) | [501](/filings/0001193125-26-435875.md) | [410](/filings/0001193125-26-201403.md) | [508](/filings/0001193125-26-335107.md) | [876](/filings/0001193125-26-435875.md) |
| Current assets | $m | [1,430](/filings/0000950170-25-024839.md) | [1,406](/filings/0000950170-24-054464.md) | [1,453](/filings/0000950170-24-091772.md) | [1,525](/filings/0000950170-24-121449.md) | [1,607](/filings/0001193125-26-051976.md) | [1,584](/filings/0000950170-25-063937.md) | [1,676](/filings/0000950170-25-102042.md) | [1,756](/filings/0001193125-25-260708.md) | [1,855](/filings/0001193125-26-435875.md) | [1,914](/filings/0001193125-26-201403.md) | [2,250](/filings/0001193125-26-335107.md) | [2,962](/filings/0001193125-26-435875.md) |
| Total assets | $m | [3,324](/filings/0000950170-25-024839.md) | [3,299](/filings/0000950170-24-054464.md) | [3,343](/filings/0000950170-24-091772.md) | [3,419](/filings/0000950170-24-121449.md) | [3,472](/filings/0001193125-26-051976.md) | [3,455](/filings/0000950170-25-063937.md) | [3,578](/filings/0000950170-25-102042.md) | [3,721](/filings/0001193125-25-260708.md) | [3,840](/filings/0001193125-26-435875.md) | [3,981](/filings/0001193125-26-201403.md) | [4,416](/filings/0001193125-26-335107.md) | [5,563](/filings/0001193125-26-435875.md) |
| Current liabilities | $m | [704](/filings/0000950170-25-024839.md) | [671](/filings/0000950170-24-054464.md) | [712](/filings/0000950170-24-091772.md) | [763](/filings/0000950170-24-121449.md) | [809](/filings/0001193125-26-051976.md) | [765](/filings/0000950170-25-063937.md) | [828](/filings/0000950170-25-102042.md) | [905](/filings/0001193125-25-260708.md) | [962](/filings/0001193125-26-435875.md) | [1,015](/filings/0001193125-26-201403.md) | [1,264](/filings/0001193125-26-335107.md) | [1,773](/filings/0001193125-26-435875.md) |
| Long-term debt | $m | [914](/filings/0000950170-25-024839.md) | [914](/filings/0000950170-24-054464.md) | [913](/filings/0000950170-24-091772.md) | [913](/filings/0000950170-24-121449.md) | [914](/filings/0001193125-26-051976.md) | [914](/filings/0000950170-25-063937.md) | [913](/filings/0000950170-25-102042.md) | [913](/filings/0001193125-25-260708.md) | [912](/filings/0001193125-26-435875.md) | [912](/filings/0001193125-26-201403.md) | [969](/filings/0001193125-26-335107.md) | [1,460](/filings/0001193125-26-435875.md) |
| Current portion of debt | $m | [3.5](/filings/0000950170-25-024839.md) | [2.6](/filings/0000950170-24-054464.md) | [2.6](/filings/0000950170-24-091772.md) | [3.5](/filings/0000950170-24-121449.md) | [3.8](/filings/0001193125-26-051976.md) | [3.8](/filings/0000950170-25-063937.md) | [3.8](/filings/0000950170-25-102042.md) | [3.8](/filings/0001193125-25-260708.md) | [3.8](/filings/0001193125-26-435875.md) | [3.9](/filings/0001193125-26-201403.md) | [4.0](/filings/0001193125-26-335107.md) | [184](/filings/0001193125-26-435875.md) |
| Shareholders' equity | $m | [1,511](/filings/0001193125-26-051976.md) | [1,521](/filings/0001193125-25-260708.md) | [1,529](/filings/0001193125-25-260708.md) | [1,547](/filings/0001193125-25-260708.md) | [1,564](/filings/0001193125-26-435875.md) | [1,587](/filings/0001193125-26-435875.md) | [1,637](/filings/0001193125-26-435875.md) | [1,701](/filings/0001193125-26-435875.md) | [1,762](/filings/0001193125-26-435875.md) | [1,838](/filings/0001193125-26-435875.md) | [1,934](/filings/0001193125-26-435875.md) | [2,042](/filings/0001193125-26-435875.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2024-01-01) | Q1 FY2024 (2024-04-01) | Q2 FY2024 (2024-07-01) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-29) | Q4 FY2025 (2025-12-29) | Q1 FY2026 (2026-03-30) | Q2 FY2026 (2026-06-29) | Q3 FY2026 (2026-09-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.5 d](/filings/0001193125-26-051976.md) | [43.9](/filings/0000950170-25-063937.md) | [41.9 d](/filings/0000950170-25-102042.md) | [65.1 d](/filings/0001193125-25-260708.md) | [86.1 d](/filings/0001193125-26-051976.md) | [(10.7)](/filings/0001193125-26-201403.md) | [97.8 d](/filings/0001193125-26-335107.md) | [142 d](/filings/0001193125-26-435875.md) | [62.9 d](/filings/0001193125-26-051976.md) | [21.7](/filings/0001193125-26-201403.md) | [96.4 d](/filings/0001193125-26-335107.md) | [155 d](/filings/0001193125-26-435875.md) |
| Capital expenditure | $m | [46.1 d](/filings/0001193125-26-051976.md) | [49.3](/filings/0000950170-25-063937.md) | [39.5 d](/filings/0000950170-25-102042.md) | [40.9 d](/filings/0001193125-25-260708.md) | [56.0 d](/filings/0001193125-26-051976.md) | [63.3](/filings/0001193125-26-201403.md) | [60.4 d](/filings/0001193125-26-335107.md) | [99.5 d](/filings/0001193125-26-435875.md) | [69.4 d](/filings/0001193125-26-051976.md) | [107](/filings/0001193125-26-201403.md) | [62.4 d](/filings/0001193125-26-335107.md) | [82.4 d](/filings/0001193125-26-435875.md) |
| Share repurchases | $m | [9.8 d](/filings/0001193125-26-051976.md) | [9.3](/filings/0000950170-25-063937.md) | [25.1 d](/filings/0000950170-25-102042.md) | [0.0 d](/filings/0001193125-25-260708.md) | [0.0 d](/filings/0001193125-26-051976.md) | [17.9](/filings/0001193125-26-201403.md) | [0.0 d](/filings/0001193125-26-335107.md) | [0.0 d](/filings/0001193125-26-435875.md) | [0.0 d](/filings/0001193125-26-051976.md) | [0.0](/filings/0001193125-26-201403.md) | [0.0 d](/filings/0001193125-26-335107.md) | [0.0 d](/filings/0001193125-26-435875.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-04-03) | Q2 FY2023 (2023-07-03) | Q3 FY2023 (2023-10-02) | Q1 FY2024 (2024-04-01) | Q2 FY2024 (2024-07-01) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-29) | Q1 FY2026 (2026-03-30) | Q2 FY2026 (2026-06-29) | Q3 FY2026 (2026-09-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [102](/filings/0000950170-24-054464.md) | [105](/filings/0000950170-24-091772.md) | [104](/filings/0000950170-24-121449.md) | [104](/filings/0000950170-25-063937.md) | [104](/filings/0000950170-25-102042.md) | [104](/filings/0001193125-25-260708.md) | [105](/filings/0001193125-26-201403.md) | [105](/filings/0001193125-26-335107.md) | [106](/filings/0001193125-26-435875.md) | [107](/filings/0001193125-26-201403.md) | [108](/filings/0001193125-26-335107.md) | [108](/filings/0001193125-26-435875.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 105,375,520 at 2026-10-23, from the cover of the [10-Q filed 2026-10-28](/filings/0001193125-26-435875.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 04:39 ET. No prices; not investment advice.